Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Propargyl bromide | HCID 7842 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 22876576 | HCID 22876576 | — |
| Product | HCID 86751230 | HCID 86751230 | 29% |
Reaction Steps
3.7 g (10 mmol) of (S)-1-(3-aminomethyl-1,2,4-oxadiazol-5-yl)-8-chloro-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo-[2,1-c][1,4]benzodiazepin-9-one, 30 ml of N,N-dimethylformamide, 4.27 ml (25 mmol) of N-ethyldiisopropylamine and 2.38 g (20 mmol) of propargyl bromide were stirred at room temperature for 1 hour. After evaporating the reaction solution the residue was chromatographed on 430 g of silica gel while eluting with ethyl acetate/methanol 9/1. The uniform fractions having the lower Rf were evaporated. There were obtained 1.19 g (29%) of (S)-8-chloro-11,12,13,13a-tetrahydro-1-(3-propargylamino-methyl-1,2,4-oxadiazol-5-yl)-9H-imidazo[1,5-a]pyrrolo-[2,1-c][1,4]benzodiazepin-9-one of m.p. 144°-145°, which was converted into the hydrochloride of m.p. 189°-192°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-851ad1f75c494eb3a78a5936246db13d |
|---|
| Source note | uspto-grants-1997_09 |
|---|